|
2024
|
Invention
|
Humanized anti-prostate -specific membrane antigen (psma) antibody drug conjugates.
The inventio... |
|
|
Invention
|
Interleukin-2 polypeptide conjugates and their uses.
The present invention provides methods for ... |
|
|
Invention
|
Drug linkers and antibody conjugates thereof. Disclosed herein are antibody drug conjugates (ADCs... |
|
|
Invention
|
Trop2-directed antibody-drug conjugates and uses thereof. This invention relates to anti-TROP2 an... |
|
|
Invention
|
Auristatin analogs and antibody conjugates thereof. Disclosed here are antibody-drug conjugates, ... |
|
|
Invention
|
Anti-cd70 antibody-drug conjugates. This invention relates to anti-CD70 antibodies and antibody d... |
|
2023
|
Invention
|
Pegylated bovine interferon lambda and methods of use thereof. A long-acting conjugated protein c... |
|
|
Invention
|
Methods and compositions for promoting non-natural amino acid-containing protein production.
Dis... |
|
|
Invention
|
Anti-cd3-folate conjugates and their uses.
Described herein are novel anti-CD3 antibodies conjug... |
|
|
Invention
|
Modified relaxin polypeptides and their uses.
Modified relaxin polypeptides and their uses there... |
|
|
Invention
|
Porcine g-csf variants and their uses.
The present invention relates to variants of porcine gran... |
|
2022
|
Invention
|
Modified bovine g-csf polypeptides and their uses.
Modified bovine G-CSF polypeptides and uses t... |
|
|
Invention
|
Antibody drug conjugate for anti-inflammatory applications.
Antibody drug conjugates (ADCs) comp... |
|
|
Invention
|
Interleukin-2 polypeptide conjugates and methods of use thereof.
The present invention provides ... |
|
|
Invention
|
Anti-cd70 antibody drug conjugates. This invention relates to anti-CD70 antibodies and antibody d... |
|
|
Invention
|
Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin ... |
|
|
Invention
|
Anti-her2 antibody-drug conjugates and uses thereof. Disclosed herein are antibody-drug conjugate... |
|
|
Invention
|
Modified relaxin polypeptides and their uses. Modified relaxin polypeptides and their uses thereo... |
|
2021
|
Invention
|
Antibody-tlr agonist conjugates, methods and uses thereof.
Disclosed herein are TLR-agonists com... |
|
|
Invention
|
Antibody-tlr agonist conjugates, methods and uses thereof. Disclosed herein are TLR-agonists comp... |
|
|
G/S
|
Biological and biochemical preparations, namely, novel
bio-therapeutics in the nature of protein... |
|
|
G/S
|
Biological and biochemical preparations for the treatment of cancer, namely, novel bio-therapeuti... |
|
|
Invention
|
Interleukin-2 polypeptide conjugates and methods of use thereof. The present invention provides c... |
|
|
Invention
|
Pegylated porcine interferon and methods of use thereof.
Disclosed herein are porcine interferon... |
|
|
Invention
|
Uses of anti-cd3 antibody folate bioconjugates. Described herein are anti-CD3 antibody folate bio... |
|
|
Invention
|
Modified fgf-21 polypeptides with non-naturally encoded amino acids. Modified FGF-21 polypeptides... |
|
|
G/S
|
Biological and biochemical preparations for the treatment of cancer, namely, protein expression s... |
|
|
G/S
|
Development of new technology for others in the field of protein engineering; scientific research... |
|
2020
|
Invention
|
Antibody peptide conjugates that have agonist activity at both the glucagon and glucagon-like pep... |
|
|
Invention
|
Prostate-specific membrane antigen antibody drug conjugates.
This invention relates to prostate-... |
|
|
Invention
|
Nucleic acids encoding modified relaxin polypeptides. Modified relaxin polypeptides and their use... |
|
|
Invention
|
Methods of treating heart failure and fibrotic disorders using modified relaxin polypeptides. Mod... |
|
|
Invention
|
Compositions containing, methods and uses of antibody-tlr agonist conjugates.
Disclosed herein a... |
|
|
Invention
|
Compositions containing, methods and uses of antibody-tlr agonist conjugates. Disclosed herein ar... |
|
2019
|
Invention
|
Interleukin-10 polypeptide conjugates, dimers thereof, and their uses.
The present invention pro... |
|
|
Invention
|
Interleukin-10 polypeptide conjugates, dimers thereof, and their uses. The present invention prov... |
|
|
Invention
|
Interleukin-2 polypeptide conjugates and their uses. The present invention provides methods for t... |
|
|
Invention
|
Anti-cd3 antibody folate bioconjugates and their uses.
Described herein are novel anti-CD3 Folat... |
|
|
Invention
|
Anti-cd3 antibody folate bioconjugates and their uses. Described herein are novel anti-CD3 Folate... |
|
|
Invention
|
A method for optimizing antibody expression.
Disclosed herein are methods, compositions and comp... |
|
|
Invention
|
Humanized anti-prostate -specific membrane antigen (psma) antibody drug conjugates. The invention... |
|
2018
|
Invention
|
Porcine g-csf variants and their uses. The present invention relates to variants of porcine granu... |
|
|
Invention
|
Methods and compositions for promoting non-natural amino acid-containing protein production. Disc... |
|
2016
|
Invention
|
Antibody drug conjugate for anti-inflammatory applications. Antibody drug conjugates (ADCs) compr... |
|
2006
|
G/S
|
Development of new technology for others in the field of protein engineering; scientific and indu... |
